ICCM IceCure Medical Ltd.
Fundamentals / CIK 0001584371 / USDIceCure Medical Ltd. reported $3.38M in revenue and a net loss of $15.06M for the fiscal year ended December 31, 2025 (up 2.7% year over year), with a 36.3% gross margin and a -446.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ICCM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$3.38M +2.7% YoY
-
Operating Income FY 2025-$15.09M -446.7% margin
-
Net Income FY 2025-$15.06M -445.6% net margin
-
Diluted EPS FY 2025$0.24 Split-adjusted
-
Free Cash Flow FY 2025-$14.61M -432.4% FCF margin
-
Cash & ST Investments Dec 31, 2025$8.90M Total debt: $230K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $3.38M | $3.29M | $3.23M | $3.08M | $4.14M | $3.87M |
| Cost of Revenue | $2.15M | $1.84M | $1.93M | $1.64M | $1.94M | $1.42M |
| Gross Profit | $1.23M | $1.45M | $1.30M | $1.45M | $2.19M | $2.44M |
| Research & Development | $7.43M | $7.10M | $8.27M | $9.12M | $5.88M | $3.81M |
| Selling, General & Admin | $8.89M | $10.05M | $8.60M | $735K | $177K | $120K |
| Operating Income | -$15.09M | -$15.70M | -$15.58M | -$16.74M | -$9.72M | -$4.14M |
| EBITDA | -$14.80M | -$15.36M | -$15.25M | -$16.49M | -$9.60M | -$4.08M |
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M |
| Basic EPS | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 |
| Diluted EPS | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 |
| Basic Shares Outstanding | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M |
| Diluted Shares Outstanding | 63.6M | 50.9M | 45.6M | 37.0M | 28.5M | 17.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.90M | $7.56M | $10.53M | $23.66M | $25.62M | $3.50M |
| Short-Term Investments | -- | -- | $529K | -- | -- | -- |
| Cash & Short-Term Investments | $8.90M | $7.56M | $11.06M | $23.66M | $25.62M | $3.50M |
| Accounts Receivable, Net | $331K | $221K | $103K | $78K | $456K | $94K |
| Inventory | $2.62M | $1.99M | $2.27M | $2.86M | $1.96M | $1.06M |
| Total Current Assets | $12.61M | $10.75M | $14.18M | $28.13M | $30.32M | $9.59M |
| Property, Plant & Equipment, Net | $993K | $1.25M | $1.51M | $1.36M | $713K | $307K |
| Total Non-Current Assets | $1.28M | $1.82M | $2.23M | $2.06M | $1.96M | $650K |
| Total Assets | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M |
| Accounts Payable | $863K | $1.23M | $502K | $714K | $881K | $645K |
| Deferred Revenue (Current) | $255K | $334K | $187K | $646K | $884K | $1.38M |
| Other Current Liabilities | $1.10M | $1.23M | $3.15M | $3.46M | $2.92M | $2.85M |
| Total Current Liabilities | $4.82M | $5.51M | $3.87M | $4.34M | $4.02M | $3.71M |
| Long-Term Debt | $13K | $161K | -- | -- | -- | -- |
| Total Non-Current Liabilities | $13K | $161K | $376K | $430K | $1.30M | $877K |
| Total Liabilities | $4.84M | $5.67M | $4.25M | $4.77M | $5.32M | $4.59M |
| Total Debt (incl. Leases) | $230K | $620K | $599K | $597K | $909K | $332K |
| Retained Earnings | -$120.4M | -$105.4M | -$90.06M | -$75.41M | -$58.43M | -$48.54M |
| Total Stockholders' Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
| Total Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.90M | $7.56M | $10.53M | $23.66M | $25.62M | $3.50M |
| Short-Term Investments | -- | -- | $529K | -- | -- | -- |
| Cash & Short-Term Investments | $8.90M | $7.56M | $11.06M | $23.66M | $25.62M | $3.50M |
| Accounts Receivable, Net | $331K | $221K | $103K | $78K | $456K | $94K |
| Inventory | $2.62M | $1.99M | $2.27M | $2.86M | $1.96M | $1.06M |
| Total Current Assets | $12.61M | $10.75M | $14.18M | $28.13M | $30.32M | $9.59M |
| Property, Plant & Equipment, Net | $993K | $1.25M | $1.51M | $1.36M | $713K | $307K |
| Total Non-Current Assets | $1.28M | $1.82M | $2.23M | $2.06M | $1.96M | $650K |
| Total Assets | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M |
| Accounts Payable | $863K | $1.23M | $502K | $714K | $881K | $645K |
| Deferred Revenue (Current) | $255K | $334K | $187K | $646K | $884K | $1.38M |
| Other Current Liabilities | $1.10M | $1.23M | $3.15M | $3.46M | $2.92M | $2.85M |
| Total Current Liabilities | $4.82M | $5.51M | $3.87M | $4.34M | $4.02M | $3.71M |
| Long-Term Debt | $13K | $161K | -- | -- | -- | -- |
| Total Non-Current Liabilities | $13K | $161K | $376K | $430K | $1.30M | $877K |
| Total Liabilities | $4.84M | $5.67M | $4.25M | $4.77M | $5.32M | $4.59M |
| Total Debt (incl. Leases) | $230K | $620K | $599K | $597K | $909K | $332K |
| Retained Earnings | -$120.4M | -$105.4M | -$90.06M | -$75.41M | -$58.43M | -$48.54M |
| Total Stockholders' Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
| Total Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M |
| Depreciation & Amortization | $295K | $332K | $323K | $248K | $127K | $63K |
| Stock-Based Compensation | $1.37M | $869K | $1.31M | $1.86M | $316K | $229K |
| Change in Receivables | -$110K | -$118K | -$25K | $378K | -$362K | -$77K |
| Change in Inventory | -$637K | $287K | $582K | -$902K | -$891K | -- |
| Change in Payables | -$369K | $730K | -$212K | -$167K | $236K | $217K |
| Operating Cash Flow | -$14.57M | -$12.56M | -$12.55M | -$14.29M | -$12.61M | -$3.69M |
| Capital Expenditure | -$36K | -$71K | -$480K | -$891K | -$533K | -$223K |
| Free Cash Flow | -$14.61M | -$12.63M | -$13.03M | -$15.18M | -$13.14M | -$3.91M |
| Purchases of Investments | -$5.00M | -$1.37M | -$500K | -- | -- | -- |
| Investing Cash Flow | -$36K | $446K | -$684K | -$891K | $3.79M | -$4.67M |
| Common Stock Issued | -- | $9.19M | -- | $13.57M | $14.59M | $5.85M |
| Financing Cash Flow | $15.83M | $9.19M | $83K | $13.58M | $30.89M | $5.86M |
| Net Change in Cash | $1.22M | -$2.93M | -$13.15M | -$1.61M | $22.08M | -$2.50M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | 36.3% | 44.1% | 40.3% | 46.8% | 53.0% | 63.2% |
| Operating Margin | -446.7% | -476.9% | -482.4% | -542.6% | -235.0% | -107.1% |
| Net Profit Margin | -445.6% | -465.5% | -453.8% | -550.3% | -239.1% | -96.4% |
| Return on Equity (ROE) | -166.4% | -222.0% | -120.5% | -66.8% | -36.7% | -66.0% |
| Return on Assets (ROA) | -108.4% | -121.8% | -89.3% | -56.2% | -30.7% | -36.4% |
| Current Ratio | 2.61x | 1.95x | 3.66x | 6.49x | 7.54x | 2.58x |
| Quick Ratio | 2.07x | 1.59x | 3.08x | 5.83x | 7.06x | 2.30x |
| Debt to Equity | 0.03x | 0.09x | 0.05x | 0.02x | 0.03x | 0.06x |
| Revenue Growth (YoY) | +2.7% | +1.9% | +4.7% | -25.4% | +7.0% | -- |
| Gross Profit Growth (YoY) | -15.5% | +11.6% | -10.0% | -34.2% | -10.2% | -- |
| EPS Growth (YoY) | -20.0% | -6.3% | -30.4% | +31.4% | +59.1% | -- |
| 5Y Revenue / Share Growth | -76.5% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.